CVRx, Inc. Increase (Decrease) in Accounts Receivable
CVRx, Inc. (CVRX) reported Increase (Decrease) in Accounts Receivable of -$1.26 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- CVRx, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $297.00K.
- CVRx, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$1.56M.
- CVRx, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $2.46M, a 945.11% increase year-over-year.
- CVRx, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $1.06M, a 147.31% increase year-over-year.
- CVRx, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $1.40M, a 18.64% decline from fiscal 2024.
- CVRx, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $1.72M, a 16.12% decline from fiscal 2023.
- CVRx, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $2.05M, a 30.47% decline from fiscal 2022.
- CVRx, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $2.94M, a 130.18% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $297.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.26M 10-Q · filed 2026-08-06 | $1.19M derived: sum of 3 quarters · filed 2026-08-06 | $2.25M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$1.56M 10-Q · filed 2026-05-12 | $895.00K derived: sum of 2 quarters · filed 2026-05-12 | $1.95M derived: sum of 3 quarters · filed 2026-05-12 | $92.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $3.51M derived: sum of 2 quarters · filed 2026-02-13 | $1.65M derived: sum of 3 quarters · filed 2026-08-06 | $1.40M 10-K · filed 2026-02-13 |
| 2025-09-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$803.00K derived: sum of 2 quarters · filed 2026-08-06 | -$1.06M 10-Q · filed 2025-11-06 | -$824.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.12M 10-Q · filed 2026-08-06 | -$1.88M derived: sum of 3 quarters · filed 2026-08-06 | -$1.45M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$256.00K 10-Q · filed 2026-05-12 | -$21.00K derived: sum of 2 quarters · filed 2026-05-12 | $406.00K derived: sum of 3 quarters · filed 2026-05-12 | $517.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $235.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $662.00K derived: sum of 2 quarters · filed 2026-02-13 | $773.00K derived: sum of 3 quarters · filed 2026-02-13 | $1.72M 10-K · filed 2026-02-13 |
| 2024-09-30 | $427.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $538.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.48M 10-Q · filed 2025-11-06 | $2.66M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $111.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $1.05M 10-Q · filed 2025-08-05 | $2.23M derived: sum of 3 quarters · filed 2025-08-05 | $1.88M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $944.00K 10-Q · filed 2025-05-09 | $2.12M derived: sum of 2 quarters · filed 2025-05-09 | $1.77M derived: sum of 3 quarters · filed 2025-05-09 | $2.06M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $825.00K derived: sum of 2 quarters · filed 2025-02-18 | $1.12M derived: sum of 3 quarters · filed 2025-02-18 | $2.05M 10-K · filed 2025-02-18 |
| 2023-09-30 | -$354.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | -$62.00K derived: sum of 2 quarters · filed 2024-11-01 | $868.00K 10-Q · filed 2024-11-01 | $1.07M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $292.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $1.22M 10-Q · filed 2024-08-02 | $1.43M derived: sum of 3 quarters · filed 2024-08-02 | $3.13M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $930.00K 10-Q · filed 2024-05-10 | $1.14M derived: sum of 2 quarters · filed 2024-05-10 | $2.83M derived: sum of 3 quarters · filed 2024-05-10 | $2.76M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $207.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $1.90M derived: sum of 2 quarters · filed 2024-02-09 | $1.83M derived: sum of 3 quarters · filed 2024-02-09 | $2.94M 10-K · filed 2024-02-09 |
| 2022-09-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $1.62M derived: sum of 2 quarters · filed 2023-10-31 | $2.74M 10-Q · filed 2023-10-31 | $1.88M derived: sum of 4 quarters · filed 2023-10-31 |
| 2022-06-30 | -$72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $1.04M 10-Q · filed 2023-08-03 | $180.00K derived: sum of 3 quarters · filed 2023-08-03 | $1.36M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $1.11M 10-Q · filed 2023-05-11 | $252.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.43M derived: sum of 3 quarters · filed 2023-05-11 | $1.96M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$861.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $316.00K derived: sum of 2 quarters · filed 2023-02-10 | $848.00K derived: sum of 3 quarters · filed 2023-02-10 | $1.28M 10-K · filed 2023-02-10 |
| 2021-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $1.71M derived: sum of 2 quarters · filed 2022-11-04 | $2.14M 10-Q · filed 2022-11-04 | $2.84M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $532.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $963.00K 10-Q · filed 2022-08-01 | $1.66M derived: sum of 3 quarters · filed 2022-08-01 | $1.19M derived: sum of 4 quarters · filed 2022-08-01 |
| 2021-03-31 | $431.00K 10-Q · filed 2022-05-02 | $1.13M derived: sum of 2 quarters · filed 2022-05-02 | $656.00K derived: sum of 3 quarters · filed 2022-05-02 | |
| 2020-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $225.00K derived: sum of 2 quarters · filed 2022-02-22 | $562.00K 10-K · filed 2022-02-22 | |
| 2020-09-30 | -$475.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$138.00K 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | $337.00K 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |